Matthew Price Selected Research

xemilofiban

4/2009

Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew Price Research Topics

Disease

11	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2021 - 12/2011
3	Wounds and Injuries (Trauma) 12/2014 - 04/2014
2	Neoplasms (Cancer) 02/2022 - 12/2015
2	Thrombosis (Thrombus) 04/2015 - 09/2013
2	Hemorrhage 04/2013 - 04/2009
2	Poisoning 04/2007 - 07/2006
1	Ovarian Neoplasms (Ovarian Cancer) 02/2022
1	Panic Disorder (Panic Attack) 01/2021
1	Atrial Fibrillation 01/2020
1	Infections 01/2018
1	HIV Seropositivity 01/2018
1	Syndrome (Syndromes) 01/2017
1	Inflammation (Inflammations) 12/2015
1	Prostatic Neoplasms (Prostate Cancer) 12/2015
1	Fibrosis (Cirrhosis) 12/2015
1	Acute Coronary Syndrome 04/2013
1	Social Phobia 11/2011
1	Myocardial Infarction 04/2009
1	Aerophobia 12/2008
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2007
1	Intussusception 04/2007
1	HIV Infections (HIV Infection) 02/2007
1	Organophosphate Poisoning 07/2006
1	Hypothermia 07/2006

Drug/Important Bio-Agent (IBA)

3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2021
2	Opioid Analgesics (Opioids)IBA 01/2018 - 01/2017
2	Alprazolam (Xanax)FDA LinkGeneric 01/2016 - 06/2014
2	Cycloserine (Seromycin)FDA Link 01/2016 - 06/2014
2	Biological ProductsIBA 06/2015 - 12/2014
2	Nerve AgentsIBA 04/2007 - 07/2006
2	asoxime chloride (H16)IBA 04/2007 - 07/2006
2	PhysostigmineIBA 04/2007 - 07/2006
2	Scopolamine (Hyoscine)FDA Link 04/2007 - 07/2006
1	chondroitin sulfate proteoglycan 4IBA 02/2022
1	Zinc Finger E-box-Binding Homeobox 1IBA 02/2022
1	Cisplatin (Platino)FDA LinkGeneric 02/2022
1	Proteins (Proteins, Gene)FDA Link 02/2022
1	SolutionsIBA 01/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2020
1	Pharmaceutical PreparationsIBA 01/2018
1	chemotactic factor inactivatorIBA 01/2017
1	Hormones (Hormone)IBA 01/2016
1	Peptides (Polypeptides)IBA 12/2015
1	Hyaluronic Acid (Hyaluronan)IBA 12/2015
1	Collagen Type I (Type I Collagen)IBA 12/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2015
1	cangrelorIBA 04/2013
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2011
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2011
1	Glycoproteins (Glycoprotein)IBA 04/2009
1	xemilofibanIBA 04/2009
1	VaccinesIBA 11/2007
1	methyl nitrateIBA 04/2007
1	RNA (Ribonucleic Acid)IBA 02/2007
1	N(6)-cyclopentyladenosineIBA 07/2006
1	VX (EDIM)IBA 07/2006
1	SomanIBA 07/2006

Therapy/Procedure

6	Therapeutics 04/2020 - 07/2006
2	Ligation 01/2020 - 04/2015
2	Stents 09/2013 - 04/2013
1	Adjuvant Chemotherapy 02/2022
1	Drug Therapy (Chemotherapy) 02/2022
1	Psychology Biofeedback (Biofeedback) 01/2021
1	Aftercare (After-Treatment) 11/2011
1	Percutaneous Coronary Intervention 04/2009
1	Blood Transfusion (Blood Transfusions) 04/2009